SCHEMBL7097840

SCHEMBL7097840

O=C(COc1cccc([N+](=O)[O-])c1)Nc1cc(Cl)cc(Cl)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
KMT2A Q03164 5/20 0.65
MEN1 O00255 4/20 0.65
POLB P06746 3/20 0.65
CETP P11597 1/20 0.60
THRB P10828 1/20 0.55
HPGD P15428 1/20 0.55
S1PR4 O95977 1/20 0.54
MAPT P10636 4/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
ROCK2 O75116 1/20 0.50
ROCK1 Q13464 1/20 0.50
NOTUM Q6P988 1/20 0.50
LMNA P02545 1/20 0.49
ENPP2 Q13822 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8977175 0.86 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1POLBCETP
SCHEMBL8977180 0.81 ALDH1A1 (0.78) ALDH1A1KMT2AMEN1POLBTHRB
SCHEMBL7098597 0.80 NOTUM (0.54) ALDH1A1KMT2AMEN1POLBHPGD
SCHEMBL9911322 0.79 KMT2A (0.63) ALDH1A1KMT2AMEN1POLBTHRB
SCHEMBL18328491 0.79 ALDH1A1 (0.67) ALDH1A1KMT2AMEN1POLBCETP
SCHEMBL30601989 0.77 CHRNB2 (0.55) ALDH1A1KMT2AMEN1POLBTHRB
SCHEMBL27468480 0.77 CHRNB2 (0.55) ALDH1A1KMT2AMEN1POLBTHRB
SCHEMBL7097558 0.77 MAPK1 (0.57) KMT2AMEN1HPGDMAPTROCK2
SCHEMBL14547780 0.76 ALDH1A1 (0.60) ALDH1A1KMT2AMEN1POLBTHRB
SCHEMBL17898573 0.76 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1POLBCETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339668-A2 BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS GUILFORD PHARMACEUTICALS INC. (US) 2003-09-03 EP disclosed
US-20020127605-A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use GUILFORD PHARMACEUTICALS, INC. 2002-09-12 US disclosed
WO-2002044126-A2 BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS GUILFORD PHARMACEUTICALS INC. (US) 2002-06-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020127605-A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use PPIG, PIN1, PPIH ALDH1A1 1905/4885KMT2A 4656/4885MEN1 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.